FR3375M - New drug endowed in particular with antiphlébitic activity. - Google Patents

New drug endowed in particular with antiphlébitic activity.

Info

Publication number
FR3375M
FR3375M FR964186A FR964186A FR3375M FR 3375 M FR3375 M FR 3375M FR 964186 A FR964186 A FR 964186A FR 964186 A FR964186 A FR 964186A FR 3375 M FR3375 M FR 3375M
Authority
FR
France
Prior art keywords
antiphlébitic
activity
new drug
endowed
drug endowed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR964186A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR964186A priority Critical patent/FR3375M/en
Application granted granted Critical
Publication of FR3375M publication Critical patent/FR3375M/en
Expired legal-status Critical Current

Links

FR964186A 1964-02-18 1964-02-18 New drug endowed in particular with antiphlébitic activity. Expired FR3375M (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR964186A FR3375M (en) 1964-02-18 1964-02-18 New drug endowed in particular with antiphlébitic activity.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR964186A FR3375M (en) 1964-02-18 1964-02-18 New drug endowed in particular with antiphlébitic activity.

Publications (1)

Publication Number Publication Date
FR3375M true FR3375M (en) 1965-06-14

Family

ID=8823416

Family Applications (1)

Application Number Title Priority Date Filing Date
FR964186A Expired FR3375M (en) 1964-02-18 1964-02-18 New drug endowed in particular with antiphlébitic activity.

Country Status (1)

Country Link
FR (1) FR3375M (en)

Similar Documents

Publication Publication Date Title
NL144835C (en) MEDICINAL INJECTOR.
DK116466B (en) Infusion set.
DK114717B (en) Infusion set.
FR3715M (en) Improved antithermics and antirheumatic drugs.
FR1478062A (en) Injection syringe
FR3060M (en) New drug endowed in particular with hypocholesterolemic activity.
FR4771M (en) NEW MEDICINES WITH PARTICULARLY CALMING ACTIVITY
FR1466480A (en) Injection syringe
FR3597M (en) New preparations with adrenocorticotropic hormone activity and their manufacture.
FR1412547A (en) Injection syringe
FR3375M (en) New drug endowed in particular with antiphlébitic activity.
FR3787M (en) New drug endowed in particular with antimitotic activity.
FR3012M (en) New drugs endowed in particular with hypocholesterolemic activity.
FR2818M (en) New drug endowed in particular with stathmokinetic activity.
FR2655M (en) New drug endowed in particular with stathmokinetic activity.
FR2652M (en) New drug endowed in particular with stathmokinetic activity.
FR3242M (en) New drug endowed in particular with hypocholesterolemic activity.
FR2419M (en) New drugs endowed in particular with stathmokinetic activity.
FR3638M (en) New drug active on the central nervous system and endowed in particular with psychotonic effect.
FR3180M (en) New drug endowed in particular with antimitotic activity.
FR2994M (en) New drug endowed in particular with antimitotic activity.
FR2731M (en) New drug endowed in particular with antimitotic activity.
FR2712M (en) New drug endowed in particular with antimitotic activity.
FR2926M (en) New drug endowed in particular with antimitotic activity.
FR2420M (en) New drug endowed in particular with antimitotic activity.